Accelerate Diagnostics Correlations
| AXDX Stock | USD 1.58 0.01 0.64% |
The current 90-days correlation between Accelerate Diagnostics and ProSomnus, Common Stock is -0.23 (i.e., Very good diversification). The correlation of Accelerate Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Accelerate Diagnostics Correlation With Market
Good diversification
The correlation between Accelerate Diagnostics and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Accelerate Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
Accelerate |
Moving together with Accelerate Stock
Moving against Accelerate Stock
| 0.5 | DYAI | Dyadic International | PairCorr |
| 0.47 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.37 | NTLA | Intellia Therapeutics | PairCorr |
| 0.44 | EMBC | Embecta Corp | PairCorr |
| 0.37 | RMD | ResMed Inc | PairCorr |
| 0.31 | COO | Cooper Companies, | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Accelerate Stock performing well and Accelerate Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Accelerate Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CVRX | 3.83 | 0.82 | 0.16 | 2.88 | 3.57 | 10.68 | 41.08 | |||
| NPCE | 3.53 | 0.74 | 0.20 | 1.25 | 2.85 | 9.73 | 35.38 | |||
| ANIK | 1.72 | (0.69) | 0.00 | (0.28) | 0.00 | 3.09 | 34.28 | |||
| AXGN | 2.33 | 0.07 | 0.02 | 0.19 | 3.64 | 4.75 | 21.60 | |||
| AORT | 1.22 | 0.07 | 0.06 | 0.19 | 1.32 | 2.65 | 9.51 | |||
| SGHT | 3.01 | (1.10) | 0.00 | (0.22) | 0.00 | 6.65 | 18.22 | |||
| OFIX | 1.82 | (0.01) | 0.01 | 0.12 | 1.97 | 3.90 | 12.11 | |||
| AVNS | 1.71 | (0.61) | 0.00 | (0.21) | 0.00 | 3.01 | 20.91 | |||
| CNMD | 1.82 | (0.15) | 0.00 | (0.02) | 0.00 | 4.46 | 10.92 | |||
| KIDS | 2.54 | (0.47) | 0.00 | (0.34) | 0.00 | 4.85 | 16.62 |
Accelerate Diagnostics Corporate Management
| Lawrence Mertz | Chief Officer | Profile | |
| Michael Bridge | Gen VP | Profile | |
| Laura Costa | VP Support | Profile | |
| Rita Boukamel | Senior EMEA | Profile | |
| Maya Gowri | Senior Operations | Profile |